MedMira Inc MMIRF

Primary Symbol: V.MIR

Healthcare Medical Devices

MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.

TSXV:MIR - Post by User

MedMira Inc > medmira financial year 2022 over 1/2 finished

<< Previous

Bullboard Posts

Next >>

Comment by kyoung28on Feb 15, 2022 7:14pm

175 Views

Post# 34432019

RE:medmira financial year 2022 over 1/2 finished

Absolutely we need a tangible progress like SALES. Another CE approved products won’t do any good to SP.

Although I do not understand why MM didn’t pay attention to HC and missed all those golden opportunities in their own soil but suddenly went after CE approvals, I hope that they did it for reasons.
I am loosing my patience everyday and need more than just hope.

GLTA

<< Previous

Bullboard Posts

Next >>

Immigration technology stock CanPR begins trading on the TSXV